Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and early trials suggest very strong ...
The lawsuit challenges FDA decisions since 2000 that approved and loosened restrictions on abortion drugs like mifepristone, ...
Kansas City 7-OH manufacturer & seller responds to state, federal investigations amid calls for bans
Founder Vince Sanders told KSHB 41 he has invested nearly $30 million into producing and marketing synthetic 7-OH. He claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback